8-K Announcements
6Material company update
May 4, 2026·SEC
Material company update
Mar 31, 2026·SEC
Material company update
Mar 23, 2026·SEC
Crawford & Company(CRD-A)Earnings, Financials & Key Ratios
CRD-A•NYSE•Insurance & Managed Care
27.9× P/E·Price updated Jun 19, 2026
AboutCrawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, and internationally. The company's Crawford Loss Adjusting provides claims management services to insurance companies and self-insured entities risk including property, public liability, automobile, and marine insurances. Its Crawford TPA Solutions segment provides claims and risk management services for corporations in the self-insured or commercially-insured marketplace; desktop claim adjusting and claims evaluation services; initial loss reporting services for claimants; and loss mitigation and risk management information services, as well as administers loss funds established to pay claims. This segment also offers third party administration for workers' compensation, auto and liability, disability absence and medical management, and accident and health products. The company's Crawford Platform Solutions segment offers insurance through service lines, such as Contractor Connection and Networks, including losses caused by natural disasters, such as fires, hailstorms, hurricanes, earthquakes, floods, as well as man-made disasters, such as oil spills, and chemical releases. It also provides customer-centric solutions for various loss types comprising high-frequency and low-complexity claims to large complex repairs; and outsourced contractor management services to personal and commercial insurance carriers and consumer markets. The company was founded in 1941 and is headquartered in Atlanta, Georgia.Show more
- Revenue$1.31B-2.0%
- Combined Ratio94.2%-0.8%
- Net Income$20M-26.2%
- Return on Equity12.01%-33.3%
- Medical Cost Ratio75.5%+4.0%
- Operating Margin5.8%+14.6%
- Net Margin1.49%-24.7%
- ROA2.5%-24.5%
- Equity / Assets22.43%+15.9%
CRD-A Key Insights
Crawford & Company (CRD-A) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 94.2% combined ratio
- ✓Good 3Y average ROE of 17.8%
- ✓Healthy dividend yield of 2.6%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CRD-A posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CRD-A Price & Volume
Crawford & Company (CRD-A) stock price & volume — 10-year historical chart
Loading chart...
CRD-A Growth Metrics
Crawford & Company (CRD-A) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years0.57%
5 Years5.28%
3 Years2.2%
TTM-3.95%
Profit CAGR
10 Years-
5 Years-7.05%
3 Years-
TTM-41.35%
EPS CAGR
10 Years-
5 Years-6.3%
3 Years-
TTM-40.12%
Return on Capital
10 Years13.09%
5 Years12.43%
3 Years14.59%
Last Year15.9%
CRD-A Recent Earnings
Crawford & Company (CRD-A) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 4, 2026Metric
Actual
Est
EPS
$0.16-22.6%
$0.21
Rev
$310M+0.4%
$308M
Q2 2026
Mar 2, 2026Metric
Actual
Est
EPS
$0.15-33.8%
$0.23
Rev
$309M-7.2%
$333M
Q4 2025
Nov 3, 2025Metric
Actual
Est
EPS
$0.25+54.9%
$0.16
Rev
$322M-3.1%
$333M
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$0.25-6.4%
$0.27
Rev
$335M-4.5%
$350M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $0.16vs $0.21-22.6% | $310Mvs $308M+0.4% |
| Q2 2026 | Mar 2, 2026 | $0.15vs $0.23-33.8% | $309Mvs $333M-7.2% |
| Q4 2025 | Nov 3, 2025 | $0.25vs $0.16+54.9% | $322Mvs $333M-3.1% |
| Q3 2025 | Aug 4, 2025 | $0.25vs $0.27-6.4% | $335Mvs $350M-4.5% |
Based on last 12 quarters of dataView full earnings history →
CRD-A Peer Comparison
Crawford & Company (CRD-A) competitors in Claims and cost containment services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EIG | 1.09B | 46.55 | 103.44 | -2.55% | 0.95% | 0.83% | 0.04 | |
 PLMR | 2.96B | 111.70 | 15.58 | 58.16% | 20.15% | 21.74% | 0.01 | |
 JRVR | 181.58M | 3.95 | 5 | -2.83% | 4.34% | 4.72% | 0.49 | |
 MCY | 5.69B | 102.67 | 10.51 | 9.44% | 13.68% | 36.48% | 0.25 | |
 HLNE | 4.57B | 82.22 | 13.89 | 6.46% | 32.83% | 20.15% | 0.24 | |
 KINS | 235.38M | 16.25 | 5.64 | 28.39% | 14.91% | 0.11% | 0.04 | |
 ACN | 80.34B | 130.55 | 10.74 | 7.36% | 10.7% | 24.08% | 0.25 | |
 MMC | 85.27B | 174.06 | 21.28 | 7.57% | 15.6% | 26.87% | 1.62 |
Compare CRD-A vs Peers
Crawford & Company (CRD-A) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CRD-A Income Statement
Crawford & Company (CRD-A) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.16B | 1.12B | 1.05B | 1.02B | 1.14B | 1.23B | 1.32B | 1.34B | 1.31B | 1.3B |
Revenue Growth % | -1.18% | -3.5% | -6.71% | -3% | 12.11% | 8.08% | 6.96% | 1.83% | -2% | -3.95% |
Medical Costs & Claims | 842.17M | 808M | 752.77M | 737.32M | 847.43M | 924.87M | 957.85M | 973.42M | 992.21M | 956.47M |
Medical Cost Ratio % | 72.37% | 71.95% | 71.86% | 72.56% | 74.39% | 75.12% | 72.73% | 72.59% | 75.5% | 73.65% |
Gross Profit | 321.54M▲ 0% | 314.97M▼ 2.0% | 294.85M▼ 6.4% | 278.88M▼ 5.4% | 291.8M▲ 4.6% | 306.35M▲ 5.0% | 359.07M▲ 17.2% | 367.55M▲ 2.4% | 321.9M▼ 12.4% | 342.13M▲ 0% |
Gross Margin % | 27.63% | 28.05% | 28.14% | 27.44% | 25.61% | 24.88% | 27.27% | 27.41% | 24.5% | 26.35% |
Gross Profit Growth % | -1.81% | -2.04% | -6.39% | -5.42% | 4.64% | 4.99% | 17.21% | 2.36% | -12.42% | - |
Operating Expenses | 251.75M | 242.42M | 227.17M | 218.95M | 244.85M | 255.75M | 286.51M | 299.66M | 245.69M | 275.99M |
OpEx / Revenue % | 21.63% | 21.59% | 21.68% | 21.55% | 21.49% | 20.77% | 21.76% | 22.35% | 18.7% | 21.25% |
Depreciation & Amortization | 41.66M | 44.08M | 40.51M | 40.11M | 40.18M | 36.1M | 35.74M | 36.2M | 40.04M | 39.98M |
Combined Ratio % | 94% | 93.54% | 93.54% | 94.1% | 95.88% | 95.89% | 94.49% | 94.94% | 94.2% | 94.91% |
Operating Income | 69.8M▲ 0% | 72.55M▲ 3.9% | 67.68M▼ 6.7% | 59.92M▼ 11.5% | 46.95M▼ 21.6% | 50.6M▲ 7.8% | 72.57M▲ 43.4% | 67.88M▼ 6.5% | 76.21M▲ 12.3% | 66.14M▲ 0% |
Operating Margin % | 6% | 6.46% | 6.46% | 5.9% | 4.12% | 4.11% | 5.51% | 5.06% | 5.8% | 5.09% |
Operating Income Growth % | -13.9% | 3.95% | -6.71% | -11.47% | -21.65% | 7.78% | 43.4% | -6.45% | 12.26% | - |
EBITDA | 111.45M | 116.63M | 108.2M | 100.03M | 87.13M | 86.7M | 108.31M | 104.08M | 116.25M | 106.12M |
EBITDA Margin % | 9.58% | 10.39% | 10.33% | 9.84% | 7.65% | 7.04% | 8.22% | 7.76% | 8.85% | 8.17% |
Interest Expense | 9.91M | 11.4M | 11.52M | 8.19M | 6.98M | 10.97M | 19.81M | 20.3M | 17.97M | 15.81M |
Non-Operating Income | 17.63M | 17.02M | 32.53M | 0 | -3.9M | 34.59M | 5.4M | 6.47M | 23.64M | 17.67M |
Pretax Income | 42.26M▲ 0% | 44.13M▲ 4.4% | 23.64M▼ 46.4% | 39.09M▲ 65.4% | 43.86M▲ 12.2% | 5.05M▼ 88.5% | 47.36M▲ 838.5% | 41.11M▼ 13.2% | 34.6M▼ 15.8% | 32.67M▲ 0% |
Pretax Margin % | 3.63% | 3.93% | 2.26% | 3.85% | 3.85% | 0.41% | 3.6% | 3.07% | 2.63% | 2.52% |
Income Tax | 15.04M | 18.54M | 14.11M | 12.01M | 13.32M | 23.58M | 17.1M | 14.58M | 14.92M | 14.82M |
Effective Tax Rate % | 35.59% | 42.02% | 59.7% | 30.73% | 30.36% | 467.26% | 36.1% | 35.47% | 43.13% | 45.36% |
Net Income | 27.66M▲ 0% | 25.98M▼ 6.1% | 12.48M▼ 51.9% | 28.3M▲ 126.6% | 30.69M▲ 8.5% | -18.3M▼ 159.6% | 30.61M▲ 267.2% | 26.6M▼ 13.1% | 19.63M▼ 26.2% | 17.86M▲ 0% |
Net Margin % | 2.38% | 2.31% | 1.19% | 2.78% | 2.69% | -1.49% | 2.32% | 1.98% | 1.49% | 1.37% |
Net Income Growth % | -23.08% | -6.1% | -51.94% | 126.64% | 8.47% | -159.64% | 267.22% | -13.11% | -26.18% | -41.35% |
EPS (Diluted) | 0.52▲ 0% | 0.50▼ 3.8% | 0.18▼ 64.0% | 0.54▲ 200.0% | 0.57▲ 5.6% | -0.37▼ 164.9% | 0.62▲ 267.6% | 0.53▼ 14.5% | 0.39▼ 26.4% | 0.36▲ 0% |
EPS Growth % | -22.39% | -3.85% | -64% | 200% | 5.56% | -164.91% | 267.57% | -14.52% | -26.42% | -40.12% |
EPS (Basic) | 0.53 | 0.51 | 0.18 | 0.54 | 0.58 | -0.37 | 0.63 | 0.54 | 0.40 | - |
Diluted Shares Outstanding | 53.2M | 51.96M | 54.06M | 53.38M | 53.98M | 49.47M | 49.59M | 49.74M | 50.07M | 49.4M |
CRD-A Balance Sheet
Crawford & Company (CRD-A) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 787.94M | 701.44M | 760.01M | 752.98M | 852.64M | 791.51M | 799.2M | 803.75M | 764.3M | 771.65M |
Asset Growth % | 7.08% | -10.98% | 8.35% | -0.92% | 13.23% | -7.17% | 0.97% | 0.57% | -4.91% | -5.9% |
Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.44M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 370.37M | 320.85M | 315.21M | 302M | 345.92M | 351.27M | 369.35M | 374.23M | 352.41M | 186.64M |
Cash & Equivalents | 54.01M | 53.12M | 51.8M | 44.66M | 53.23M | 46.01M | 58.36M | 55.41M | 64.08M | 64.44M |
Receivables | 282.92M | 239.41M | 239.93M | 227.86M | 258.12M | 276.48M | 247.97M | 278.48M | 246.97M | 918.71M |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 6.02M | 917K | 41.36M | 0 |
Goodwill & Intangibles | 283.89M | 254.12M | 222.17M | 208.73M | 289.9M | 247.64M | 255.28M | 262.77M | 255.73M | 1.04B |
Goodwill | 96.92M | 96.89M | 80.64M | 66.54M | 116.53M | 76.62M | 76.72M | 76.37M | 76.57M | 0 |
Intangible Assets | 186.97M | 157.23M | 141.53M | 142.2M | 173.37M | 171.01M | 178.56M | 186.4M | 179.16M | 254.82M |
PP&E (Net) | 41.66M | 34.3M | 133.78M | 145.72M | 133.09M | 121.14M | 111.36M | 99.36M | 82.97M | 0 |
Other Assets | 67.66M | 70.02M | 70.88M | 70.94M | 62.46M | 51.89M | 36.97M | 42.09M | 48.5M | 319.75M |
Total Liabilities | 594.2M | 520.5M | 595.14M | 566.06M | 641.24M | 668.13M | 659.37M | 648.2M | 592.87M | 597.19M |
Total Debt | 225.67M | 190.41M | 294.78M | 239.57M | 288.67M | 346.4M | 311.53M | 309.49M | 270.27M | 271.1M |
Net Debt | 171.66M | 137.29M | 242.98M | 194.91M | 235.44M | 300.39M | 253.16M | 254.08M | 206.19M | 271.1M |
Long-Term Debt | 199.64M | 167.12M | 148.35M | 111.28M | 163.98M | 211.64M | 194.27M | 200.24M | 150.55M | 200.68M |
Short-Term Debt | 24.64M | 23.2M | 28.53M | 1.57M | 10.62M | 26.97M | 14.73M | 17.74M | 38.45M | 70.42M |
Total Current Liabilities | 256.59M | 225.31M | 236.26M | 242.79M | 303.86M | 279.49M | 299.29M | 299.73M | 309.57M | 323.25M |
Accounts Payable | 49.3M | 37.83M | 34.38M | 41.54M | 48.47M | 50.85M | 45.11M | 50.6M | 39.77M | 59.24M |
Deferred Revenue | 37.79M | 30.96M | 28.29M | 27.23M | 32.12M | 29.28M | 35.54M | 36.13M | 33.83M | 33.74M |
Other Current Liabilities | 105.02M | 97.69M | 79.81M | 93.24M | 109.24M | 91.9M | 131.08M | 129.18M | 127.97M | 159.85M |
Deferred Taxes | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 114.63M | 106.35M | 99.32M | 94.14M | 60.88M | 67.47M | 62.84M | 57.8M | 55.91M | 73.27M |
Total Equity | 193.74M▲ 0% | 180.95M▼ 6.6% | 164.88M▼ 8.9% | 186.93M▲ 13.4% | 211.4M▲ 13.1% | 123.38M▼ 41.6% | 139.83M▲ 13.3% | 155.55M▲ 11.2% | 171.43M▲ 10.2% | 174.46M▲ 0% |
Equity Growth % | 21.65% | -6.6% | -8.88% | 13.37% | 13.09% | -41.64% | 13.34% | 11.24% | 10.21% | 53.68% |
Shareholders Equity | 182.32M | 171.29M | 159.32M | 186.94M | 211.97M | 124.54M | 141.62M | 157.21M | 173.09M | 176.27M |
Minority Interest | 11.42M | 9.66M | 5.56M | -11K | -568K | -1.17M | -1.79M | -1.66M | -1.66M | -1.82M |
Retained Earnings | 269.69M | 273.61M | 249.55M | 265.25M | 266.37M | 213.09M | 228.56M | 237.95M | 233.71M | 229.96M |
Common Stock | 55.94M | 55.34M | 53.28M | 53.36M | 51.81M | 48.61M | 49.08M | 49.27M | 48.87M | 48.69M |
Accumulated OCI | -196.48M | -216.45M | -206.91M | -198.86M | -180.44M | -215.32M | -218.62M | -217.13M | -201.74M | -193.62M |
Return on Equity (ROE) | 15.67% | 13.87% | 7.22% | 16.09% | 15.41% | -10.94% | 23.26% | 18.01% | 12.01% | 10.1% |
Return on Assets (ROA) | 3.63% | 3.49% | 1.71% | 3.74% | 3.82% | -2.23% | 3.85% | 3.32% | 2.5% | 2.28% |
Equity / Assets | 24.59% | 25.8% | 21.69% | 24.82% | 24.79% | 15.59% | 17.5% | 19.35% | 22.43% | 22.61% |
Debt / Equity | 1.16x | 1.05x | 1.79x | 1.28x | 1.37x | 2.81x | 2.23x | 1.99x | 1.58x | 1.55x |
Book Value per Share | 3.64 | 3.48 | 3.05 | 3.50 | 3.92 | 2.49 | 2.82 | 3.13 | 3.42 | 3.53 |
Tangible BV per Share | -1.69 | -1.41 | -1.06 | -0.41 | -1.45 | -2.51 | -2.33 | -2.16 | -1.68 | -1.63 |
CRD-A Cash Flow Statement
Crawford & Company (CRD-A) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 40.76M | 52.42M | 75.22M | 93.18M | 54.32M | 27.63M | 103.79M | 51.62M | 101.85M | 117.02M |
Operating CF Growth % | -58.77% | 28.61% | 43.49% | 23.88% | -41.7% | -49.13% | 275.59% | -50.27% | 97.31% | 403.64% |
Operating CF / Revenue % | 3.5% | 4.67% | 7.18% | 9.17% | 4.77% | 2.24% | 7.88% | 3.85% | 7.75% | 9.01% |
Net Income | 27.22M | 25.59M | 9.53M | 27.07M | 30.55M | -18.53M | 30.61M | 26.53M | 19.68M | 17.86M |
Depreciation & Amortization | 41.66M | 44.08M | 40.51M | 40.11M | 40.18M | 36.1M | 35.74M | 36.2M | 40.04M | 39.98M |
Stock-Based Compensation | 6.66M | 6.2M | 4.11M | 4.38M | 7.58M | 4.92M | 5.6M | 5.77M | 5.19M | 266K |
Deferred Taxes | -2.36M | 7.95M | 3.04M | -9.01M | -2.99M | 7.4M | -12.28M | -2.53M | -3.33M | 0 |
Other Non-Cash Items | 19.6M | 21.33M | 17.48M | 3.91M | 104K | 38.24M | 4.32M | -997K | 3.25M | 2.23M |
Working Capital Changes | -52.02M | -52.72M | 544K | 26.7M | -21.1M | -40.49M | 39.79M | -13.34M | 37.01M | 56.68M |
Cash from Investing | -81.87M | 6.45M | -23.42M | -27.04M | -70.83M | -57.88M | -36.6M | -41.65M | -36.21M | -34.95M |
Capital Expenditures | -44.91M | -30.02M | -8.69M | -37.38M | -9.22M | -6.84M | -4.89M | 0 | 0 | -21.59M |
Acquisitions | -36.03M | 36.69M | -2.3M | 9.98M | -46.4M | -26.31M | 0 | 0 | 0 | 0 |
Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing | -926K | -218K | -12.44M | 358K | -15.2M | -24.73M | -31.71M | -41.65M | -36.21M | -13.36M |
Cash from Financing | 10.34M | -58.74M | -53.41M | -74.37M | 24.66M | 25.94M | -54.68M | -12.86M | -57.62M | -77.2M |
Dividends Paid | -13.7M | -13.53M | -13.17M | -9.64M | -12.66M | -11.84M | -12.7M | -13.76M | -14.33M | -14.54M |
Share Repurchases | -7.42M | -11.52M | -26.21M | -2.67M | -19.13M | -26.75M | -2.73M | -3.87M | -10.51M | -16.03M |
Stock Issued | 1.15M | 1.39M | 0 | 0 | 0 | 0 | 0 | 0 | 2.04M | 2.04M |
Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | -2M |
Other Financing | 34.63M | -320K | 819K | 13K | -4.12M | -2.87M | -5.75M | -3.62M | -5M | 4.57M |
Net Change in Cash | -27.56M▲ 0% | -892K▲ 96.8% | -1.32M▼ 47.6% | -7.15M▼ 442.6% | 9.03M▲ 226.4% | -7.04M▼ 178.0% | 12.9M▲ 283.1% | -3.22M▼ 124.9% | 8.22M▲ 355.5% | 6.42M▲ 0% |
Exchange Rate Effect | 3.21M | -1.02M | 293K | 1.08M | 881K | -2.74M | 386K | -326K | 198K | 1.55M |
Cash at Beginning | 81.57M | 54.01M | 53.12M | 51.8M | 44.66M | 53.69M | 46.65M | 59.55M | 56.33M | 64.55M |
Cash at End | 54.01M | 53.12M | 51.8M | 44.66M | 53.69M | 46.65M | 59.55M | 56.33M | 64.55M | 64.44M |
Free Cash Flow | -4.15M▲ 0% | 22.4M▲ 639.2% | 54.09M▲ 141.5% | 55.8M▲ 3.2% | 23.37M▼ 58.1% | -6.96M▼ 129.8% | 67.19M▲ 1064.7% | 9.97M▼ 85.2% | 94.83M▲ 851.0% | 109.1M▲ 0% |
FCF Growth % | -105.96% | 639.22% | 141.49% | 3.15% | -58.12% | -129.81% | 1064.74% | -85.16% | 850.99% | 216.01% |
FCF Margin % | -0.36% | 1.99% | 5.16% | 5.49% | 2.05% | -0.57% | 5.1% | 0.74% | 7.22% | 8.4% |
FCF per Share | -0.08 | 0.43 | 1 | 1.05 | 0.43 | -0.14 | 1.35 | 0.2 | 1.89 | 2.21 |
CRD-A Key Ratios
Crawford & Company (CRD-A) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 94% | 93.54% | 93.54% | 94.1% | 95.88% | 95.89% | 94.49% | 94.94% | 94.2% | 94.91% |
Medical Cost Ratio | 72.37% | 71.95% | 71.86% | 72.56% | 74.39% | 75.12% | 72.73% | 72.59% | 75.5% | 73.65% |
Return on Equity (ROE) | 15.67% | 13.87% | 7.22% | 16.09% | 15.41% | -10.94% | 23.26% | 18.01% | 12.01% | 10.1% |
Return on Assets (ROA) | 3.63% | 3.49% | 1.71% | 3.74% | 3.82% | -2.23% | 3.85% | 3.32% | 2.5% | 2.28% |
Equity / Assets | 24.59% | 25.8% | 21.69% | 24.82% | 24.79% | 15.59% | 17.5% | 19.35% | 22.43% | 22.61% |
Book Value / Share | 3.64 | 3.48 | 3.05 | 3.5 | 3.92 | 2.49 | 2.82 | 3.13 | 3.42 | 3.53 |
Debt / Equity | 1.16x | 1.05x | 1.79x | 1.28x | 1.37x | 2.81x | 2.23x | 1.99x | 1.58x | 1.55x |
Revenue Growth | -1.18% | -3.5% | -6.71% | -3% | 12.11% | 8.08% | 6.96% | 1.83% | -2% | -3.95% |
Related:CRD-A Dividend History·CRD-A Revenue History·CRD-A Price History·CRD-A P/E History·CRD-A Financial Ratios·CRD-A Institutional Holders
CRD-A SEC Filings & Documents
Crawford & Company (CRD-A) SEC filings — annual & quarterly reports (10-K, 10-Q)
CRD-A Frequently Asked Questions
Crawford & Company (CRD-A) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Crawford & Company (CRD-A) saw revenue decline by 2.0% over the past year.
Yes, Crawford & Company (CRD-A) is profitable, generating $17.9M in net income for fiscal year 2025 (1.5% net margin).
Dividend & Returns
Yes, Crawford & Company (CRD-A) pays a dividend with a yield of 2.63%. This makes it attractive for income-focused investors.
Crawford & Company (CRD-A) has a return on equity (ROE) of 12.0%. This is reasonable for most industries.
Industry Metrics
Crawford & Company (CRD-A) has a combined ratio of 94.2%. A ratio below 100% indicates underwriting profitability.